Chemoinformaics analysis of 3-phenylpropanol
| Molecular Weight | 136.194 | nRot | 3 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 6 |
| Exact Molecular Weight | 136.089 | nRing | 1 |
| Solubility: LogS | -1.644 | nHRing | 0 |
| Solubility: LogP | 1.806 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 23.8335 |
| nHD | 1 | BPOL | 12.0385 |
| QED | 0.669 |
| Synth | 1.305 |
| Natural Product Likeliness | 0.338 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.003 |
| HIA | 0.007 |
| CACO-2 | -4.183 |
| MDCK | 0.0000228 |
| BBB | 0.983 |
| PPB | 0.663226 |
| VDSS | 3.448 |
| FU | 0.282396 |
| CYP1A2-inh | 0.842 |
| CYP1A2-sub | 0.489 |
| CYP2c19-inh | 0.339 |
| CYP2c19-sub | 0.095 |
| CYP2c9-inh | 0.063 |
| CYP2c9-sub | 0.105 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.175 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.335 |
| CL | 10.225 |
| T12 | 0.819 |
| hERG | 0.063 |
| Ames | 0.015 |
| ROA | 0.034 |
| SkinSen | 0.629 |
| Carcinogencity | 0.321 |
| EI | 0.992 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.925446 |